2011
DOI: 10.1016/j.ijscr.2011.08.007
|View full text |Cite
|
Sign up to set email alerts
|

Middle-preserving pancreatectomy for synchronous ampullary carcinoma and solid-pseudopapillary tumor of distal pancreas

Abstract: Middle-preserving pancreatectomy is a safe and feasible option for patient with multicentric or synchronous pancreatic pathologies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 6 publications
0
2
0
Order By: Relevance
“…From data shown in Table  1, it is apparent that MPP is mainly acceptable for muticentric periampullary-pancreatic benign, borderline, low-grade malignant lesions and pancreatic metastases from other tumors in which lymphadenectomy is not necessary. However, six patients were diagnosed with primary periampullary-pancreatic invasive cancer [1,4,11,12]. One major concern that might be raised is whether MPP guarantees tumor-free margins and sufficiently extensive lymph node dissection in these situations.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…From data shown in Table  1, it is apparent that MPP is mainly acceptable for muticentric periampullary-pancreatic benign, borderline, low-grade malignant lesions and pancreatic metastases from other tumors in which lymphadenectomy is not necessary. However, six patients were diagnosed with primary periampullary-pancreatic invasive cancer [1,4,11,12]. One major concern that might be raised is whether MPP guarantees tumor-free margins and sufficiently extensive lymph node dissection in these situations.…”
Section: Discussionmentioning
confidence: 99%
“…One major concern that might be raised is whether MPP guarantees tumor-free margins and sufficiently extensive lymph node dissection in these situations. According to the surgical principles of treating pancreatic cancer [16], as long as the multicentric invasive cancers do not affect both the proximal and the distal portions of the pancreas, synchronously or metachronously, MPP should be pursued whenever possible since in theory, it would offer sufficient extent of resection and nodal clearance, as demonstrated in previous reports [1,11,12]. Although a two-stage MPP was applied in one patient who presented with multicentric metachronous pancreatic adenocarcinoma [4], we would not advocate MPP in such situations because it evidently betrays the oncological surgical resection principle [16].…”
Section: Discussionmentioning
confidence: 99%